2022-05-27| Special

Cell and Gene Therapy Landscape in Japan is Moving Beyond Oncology

by Sahana Shankar
Share To
photo credit to ASCGT

At the 25th annual meeting of the American Society for Cell and Gene Therapy, medical researchers from Japan showcased their expertise in developing gene therapy in a session titled ‘Cutting edge cell and gene therapy research in Japan’. Looking beyond oncology and genetic diseases, Japan’s biomedical community is working on developing new therapies, improving gene therapy efficiency and targeting specific tissues. The session showcased examples of the latest  developments in cell and gene therapy research in Japan. 


A roadmap to gene therapy for cardiovascular diseases


Dr. Yoshikazu Yonemitsu from Kyushu University reviewed the evolution of RNA therapy for cardiaovascular diseases and the importance of large scale, double-blinded and randomized clinical trials to eliminate biases and errors for evaluating the efficacy of cell therapy. While most gene therapy candidates focus on oncology and genetic diseases, clinical success for cardiovascular diseases has been limited.  

It's free! Log in now to read

Eli Lilly’s Tirzepatide Gets Approval in China for Weight Loss Management
Roche Reports Positive Clinical Trial Results for Two Diabetes-Related Eye Disease Therapies
7th Person in History Possibly Cured From HIV After Stem Cell Transplant for Acute Myeloid Leukemia
Large RCT Finds Time-Lapse Imaging for Embryo Selection in IVF Does Not Improve Live Birth Rates
Assessment of Supply Chain Risk Key to Improving Medicine Access
SK Biopharma and Full-Life Sign US$571.5 Million Deal for Innovative Radiopharmaceutical FL-091
Autoimmune Patients See Breakthrough Response to Allogeneic CD19-Targeted CAR-T Therapy
Scroll to Top